naphthalenediimide has been researched along with imatinib mesylate in 1 studies
| Studies (naphthalenediimide) | Trials (naphthalenediimide) | Recent Studies (post-2010) (naphthalenediimide) | Studies (imatinib mesylate) | Trials (imatinib mesylate) | Recent Studies (post-2010) (imatinib mesylate) |
|---|---|---|---|---|---|
| 231 | 0 | 177 | 11,477 | 960 | 5,773 |
| Protein | Taxonomy | naphthalenediimide (IC50) | imatinib mesylate (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.31 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collie, GW; Gunaratnam, M; Neidle, S; Parkinson, GN; Reszka, AP; Todd, AK | 1 |
1 other study(ies) available for naphthalenediimide and imatinib mesylate
| Article | Year |
|---|---|
A naphthalene diimide G-quadruplex ligand inhibits cell growth and down-regulates BCL-2 expression in an imatinib-resistant gastrointestinal cancer cell line.
Topics: Down-Regulation; Drug Resistance, Neoplasm; G-Quadruplexes; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Imides; Ligands; MCF-7 Cells; Molecular Structure; Naphthalenes; Proto-Oncogene Proteins c-bcl-2 | 2018 |